Polyphenol-conjugated nanocarrier system enhances antibody therapies for breast cancer

Researchers in Japan created PEGylated polyphenol nanocarriers that deliver antibodies into breast cancer cells by escaping endosomes, restoring p53 activity, reducing tumors by 80%, and showing minimal toxicity—advancing targeted intracellular cancer therapy.